< Back to companies

Breathomix has developed BreathBase®, which includes eNose technology linked to a cloud-solution that aims to transform the way patients are diagnosed and managed by enabling rapid diagnostic answers in the doctor’s office. BreathBase® is a combination of an easy-to-use eNose, SpiroNose®, and a constantly growing online reference database coupled with an AI-powered platform, which allow real-time, on-site analysis of composite exhaled biomarkers within seconds. Breathomix is committed to target unmet medical needs across a wide range of disease areas including but not limited to chronic respiratory disease, cancer & infectious diseases by developing & bringing together all the necessary elements of data-driven medicine in the era of precision medicine.

Only accessible to MedStartr community members. Join now

Company Info

Founded
2018
Website
www.breathomix.com/

Categories

AI / MLCancerInfectious DiseasePrecision Medicine/DiagnosticsPulmonary/ Asthma

Disease Areas

Technologies

BiosensorsBiomarkersReal-Time Processing
Only accessible to MedStartr community members. Join now

What do you think of Breathomix?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Innovation

Clinical Benefit

Feasibility

Scalability

Only accessible to MedStartr community members. Join now